Published in Infect Immun on August 01, 1997
Kinetics and in vivo induction of genetic variation of vlsE in Borrelia burgdorferi. Infect Immun (1998) 2.56
A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi. Infect Immun (2008) 2.15
Outer membrane proteins of pathogenic spirochetes. FEMS Microbiol Rev (2004) 1.87
Vector interactions and molecular adaptations of lyme disease and relapsing fever spirochetes associated with transmission by ticks. Emerg Infect Dis (2002) 1.86
Access of antibody or trypsin to an integral outer membrane protein (P66) of Borrelia burgdorferi is hindered by Osp lipoproteins. Infect Immun (1999) 1.74
Variable tick protein in two genomic groups of the relapsing fever spirochete Borrelia hermsii in western North America. Infect Immun (2005) 1.66
Population structure of the relapsing fever spirochete Borrelia hermsii as indicated by polymorphism of two multigene families that encode immunogenic outer surface lipoproteins. Infect Immun (1998) 1.40
A surface-exposed region of a novel outer membrane protein (P66) of Borrelia spp. is variable in size and sequence. J Bacteriol (1998) 1.30
Characterization of VspB of Borrelia turicatae, a major outer membrane protein expressed in blood and tissues of mice. Infect Immun (1999) 1.25
The plasminogen activation system enhances brain and heart invasion in murine relapsing fever borreliosis. J Clin Invest (1999) 1.22
Isogenic serotypes of Borrelia turicatae show different localization in the brain and skin of mice. Infect Immun (2001) 1.11
Surface protein variation by expression site switching in the relapsing fever agent Borrelia hermsii. Infect Immun (2000) 1.06
Analysis of Borrelia burgdorferi genotypes in patients with Lyme arthritis: High frequency of ribosomal RNA intergenic spacer type 1 strains in antibiotic-refractory arthritis. Arthritis Rheum (2009) 1.02
Cross-species surface display of functional spirochetal lipoproteins by recombinant Borrelia burgdorferi. Infect Immun (2004) 0.99
Infection and inflammation in skeletal muscle from nonhuman primates infected with different genospecies of the Lyme disease spirochete Borrelia burgdorferi. Infect Immun (2003) 0.99
Molecular and immunological analyses of the Borrelia turicatae Bdr protein family. Infect Immun (2000) 0.96
Role of interleukin 10 during persistent infection with the relapsing fever Spirochete Borrelia turicatae. Am J Pathol (2007) 0.95
Multiple and Diverse vsp and vlp Sequences in Borrelia miyamotoi, a Hard Tick-Borne Zoonotic Pathogen. PLoS One (2016) 0.94
Surface localization determinants of Borrelia OspC/Vsp family lipoproteins. J Bacteriol (2011) 0.91
Cardiac apoptosis in severe relapsing fever borreliosis. Infect Immun (2005) 0.91
IL-10 helps control pathogen load during high-level bacteremia. J Immunol (2008) 0.90
Crystal structure of neurotropism-associated variable surface protein 1 (Vsp1) of Borrelia turicatae. J Bacteriol (2006) 0.89
Interaction of a neurotropic strain of Borrelia turicatae with the cerebral microcirculation system. Infect Immun (2006) 0.88
The mammalian host response to borrelia infection. Wien Klin Wochenschr (2006) 0.87
Specific antibodies reactive with the 22-kilodalton major outer surface protein of Borrelia anserina Ni-NL protect chicks from infection. Infect Immun (1999) 0.86
Structure-function investigation of vsp serotypes of the spirochete Borrelia hermsii. PLoS One (2009) 0.86
Characterization of a periplasmic ATP-binding cassette iron import system of Brachyspira (Serpulina) hyodysenteriae. J Bacteriol (1999) 0.83
Interleukin 10 protects the brain microcirculation from spirochetal injury. J Neuropathol Exp Neurol (2008) 0.83
Relapsing fever borreliosis in interleukin-10-deficient mice. Infect Immun (2008) 0.82
Bacterial lipoproteins can disseminate from the periphery to inflame the brain. Am J Pathol (2010) 0.82
Oms38 is the first identified pore-forming protein in the outer membrane of relapsing fever spirochetes. J Bacteriol (2008) 0.82
Understanding tropism and immunopathological mechanisms of relapsing fever spirochaetes. Clin Microbiol Infect (2009) 0.81
Determination of Borrelia surface lipoprotein anchor topology by surface proteolysis. J Bacteriol (2011) 0.81
Stability of Borrelia burgdorferi bdr loci in vitro and in vivo. Infect Immun (2000) 0.79
Real-time monitoring of disease progression in rhesus macaques infected with Borrelia turicatae by tick bite. J Infect Dis (2014) 0.77
Interaction of variable bacterial outer membrane lipoproteins with brain endothelium. PLoS One (2010) 0.76
Variable Major Proteins as Targets for Specific Antibodies against Borrelia miyamotoi. J Immunol (2016) 0.75
Basic local alignment search tool. J Mol Biol (1990) 659.07
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47
A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65
Studies on transformation of Escherichia coli with plasmids. J Mol Biol (1983) 116.81
CLUSTAL: a package for performing multiple sequence alignment on a microcomputer. Gene (1988) 42.41
Patterns of amino acids near signal-sequence cleavage sites. Eur J Biochem (1983) 26.68
Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med (1985) 20.49
Variation in a major surface protein of Lyme disease spirochetes. Infect Immun (1984) 6.68
Antigenic variation of Borrelia hermsii. J Exp Med (1982) 6.34
Biology of Borrelia species. Microbiol Rev (1986) 6.03
Variable major proteins of Borrellia hermsii. J Exp Med (1982) 5.62
Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein. Infect Immun (1992) 4.42
Transposition of structural genes to an expression sequence on a linear plasmid causes antigenic variation in the bacterium Borrelia hermsii. Nature (1985) 4.41
Immunological and molecular polymorphisms of OspC, an immunodominant major outer surface protein of Borrelia burgdorferi. Infect Immun (1993) 4.16
Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis (1993) 3.92
Antigenic variation is associated with DNA rearrangements in a relapsing fever Borrelia. Cell (1985) 3.78
The cryptic ospC gene of Borrelia burgdorferi B31 is located on a circular plasmid. Infect Immun (1993) 3.50
Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterization. J Exp Med (1992) 3.30
Genetic and phenotypic analysis of Borrelia miyamotoi sp. nov., isolated from the ixodid tick Ixodes persulcatus, the vector for Lyme disease in Japan. Int J Syst Bacteriol (1995) 3.27
Antigenic variation of a relapsing fever Borrelia species. Annu Rev Microbiol (1990) 2.37
Outer surface protein A (OspA) from the Lyme disease spirochete, Borrelia burgdorferi: high level expression and purification of a soluble recombinant form of OspA. Protein Expr Purif (1990) 2.23
Variable major proteins of Borrelia hermsii. Epitope mapping and partial sequence analysis of CNBr peptides. J Exp Med (1985) 2.12
A flagella-less mutant of Borrelia burgdorferi. Structural, molecular, and in vitro functional characterization. J Clin Invest (1991) 1.95
Molecular basis of viral neurotropism: experimental reovirus infection. Neurology (1985) 1.94
A family of surface-exposed proteins of 20 kilodaltons in the genus Borrelia. Infect Immun (1994) 1.89
Juxtaposition of expressed variable antigen genes with a conserved telomere in the bacterium Borrelia hermsii. Proc Natl Acad Sci U S A (1990) 1.87
Variability of a bacterial surface protein and disease expression in a possible mouse model of systemic Lyme borreliosis. J Exp Med (1994) 1.73
Variable antigen genes of the relapsing fever agent Borrelia hermsii are activated by promoter addition. Mol Microbiol (1991) 1.66
Homology between Borrelia burgdorferi OspC and members of the family of Borrelia hermsii variable major proteins. Gene (1994) 1.61
Subtelomeric expression regions of Borrelia hermsii linear plasmids are highly polymorphic. Mol Microbiol (1992) 1.55
The variable antigens Vmp7 and Vmp21 of the relapsing fever bacterium Borrelia hermsii are structurally analogous to the VSG proteins of the African trypanosome. Mol Microbiol (1990) 1.52
Arthritis severity and spirochete burden are determined by serotype in the Borrelia turicatae-mouse model of Lyme disease. Infect Immun (1997) 1.51
Structural analysis of the variable major proteins of Borrelia hermsii. J Exp Med (1983) 1.50
Antigen diversity in the bacterium B. hermsii through "somatic" mutations in rearranged vmp genes. Cell (1994) 1.44
Activation of a vmp pseudogene in Borrelia hermsii: an alternate mechanism of antigenic variation during relapsing fever. Mol Microbiol (1994) 1.36
A method to determine the ability of drugs to diffuse through the blood-brain barrier. Proc Natl Acad Sci U S A (1994) 1.14
Experimental infection of the mouse brain by a relapsing fever Borrelia species: a molecular analysis. J Infect Dis (1993) 1.07
The nucleotide sequence of a linear plasmid of Borrelia burgdorferi reveals similarities to those of circular plasmids of other prokaryotes. J Bacteriol (1996) 1.03
Intragenic recombination and a chimeric outer membrane protein in the relapsing fever agent Borrelia hermsii. J Bacteriol (1993) 1.01
Molecular studies of viral pathogenesis in the central nervous system. The Linacre Lecture 1991. J R Coll Physicians Lond (1992) 0.80
Spirochetal diseases of the CNS. Neurol Clin (1986) 0.79
Lyme disease-a tick-borne spirochetosis? Science (1982) 27.50
The spirochetal etiology of Lyme disease. N Engl J Med (1983) 21.59
Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med (1985) 20.49
Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med (1983) 11.15
Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody. Infect Immun (1983) 9.60
Heterogeneity of major proteins in Lyme disease borreliae: a molecular analysis of North American and European isolates. J Infect Dis (1985) 7.69
A Borrelia-specific monoclonal antibody binds to a flagellar epitope. Infect Immun (1986) 6.80
Variation in a major surface protein of Lyme disease spirochetes. Infect Immun (1984) 6.68
Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi. Mol Microbiol (1989) 6.51
Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell (1997) 6.36
Biology of Borrelia species. Microbiol Rev (1986) 6.03
Linear plasmids of the bacterium Borrelia burgdorferi have covalently closed ends. Science (1987) 5.80
Variable major proteins of Borrellia hermsii. J Exp Med (1982) 5.62
Natural Distribution of the Ixodes dammini spirochete. Science (1983) 5.24
Antigenic variability of Borrelia burgdorferi. Ann N Y Acad Sci (1988) 5.02
Spirochetes in Ixodes dammini and mammals from Connecticut. Am J Trop Med Hyg (1983) 4.86
Training medical assistants for surgery. Bull World Health Organ (1999) 4.50
Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein. Infect Immun (1992) 4.42
Transposition of structural genes to an expression sequence on a linear plasmid causes antigenic variation in the bacterium Borrelia hermsii. Nature (1985) 4.41
Megabase-sized linear DNA in the bacterium Borrelia burgdorferi, the Lyme disease agent. Proc Natl Acad Sci U S A (1989) 4.38
Chlamydia trachomatis has penicillin-binding proteins but not detectable muramic acid. J Bacteriol (1982) 4.33
Antibodies of patients with Lyme disease to components of the Ixodes dammini spirochete. J Clin Invest (1983) 4.08
Overlapping genes. Annu Rev Genet (1983) 4.08
The prostaglandins: a family of biologically active lipids. Pharmacol Rev (1968) 3.85
Antigenic variation is associated with DNA rearrangements in a relapsing fever Borrelia. Cell (1985) 3.78
A comparative study of caesarean deliveries by assistant medical officers and obstetricians in Mozambique. Br J Obstet Gynaecol (1996) 3.53
The cryptic ospC gene of Borrelia burgdorferi B31 is located on a circular plasmid. Infect Immun (1993) 3.50
A single recombinant plasmid expressing two major outer surface proteins of the Lyme disease spirochete. Science (1985) 3.42
Organization of genes encoding two outer membrane proteins of the Lyme disease agent Borrelia burgdorferi within a single transcriptional unit. Infect Immun (1986) 3.39
Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterization. J Exp Med (1992) 3.30
Gene conversion involving the pilin structural gene correlates with pilus+ in equilibrium with pilus- changes in Neisseria gonorrhoeae. Cell (1986) 2.98
Piliation control mechanisms in Neisseria gonorrhoeae. Proc Natl Acad Sci U S A (1986) 2.96
Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. J Exp Med (1993) 2.96
Erythema chronicum migrans--a tickborne spirochetosis. Acta Trop (1983) 2.85
Clonal polymorphisms of outer membrane protein OspB of Borrelia burgdorferi. Infect Immun (1989) 2.76
DNA characterization of the spirochete that causes Lyme disease. J Clin Microbiol (1984) 2.71
Heterogeneity of outer membrane proteins in Borrelia burgdorferi: comparison of osp operons of three isolates of different geographic origins. Infect Immun (1992) 2.67
Cloning of 18S and 25S rDNAs from the pathogenic fungus Cryptococcus neoformans. J Bacteriol (1989) 2.55
The western black-legged tick, Ixodes pacificus: a vector of Borrelia burgdorferi. Am J Trop Med Hyg (1985) 2.50
Linear- and circular-plasmid copy numbers in Borrelia burgdorferi. J Bacteriol (1992) 2.45
High- and low-infectivity phenotypes of clonal populations of in vitro-cultured Borrelia burgdorferi. Infect Immun (1995) 2.39
Effects of recA mutations on pilus antigenic variation and phase transitions in Neisseria gonorrhoeae. Genetics (1987) 2.39
Economic evaluation of surgically trained assistant medical officers in performing major obstetric surgery in Mozambique. BJOG (2007) 2.37
Pilus- gonococcal variants. Evidence for multiple forms of piliation control. J Exp Med (1985) 2.33
Polymorphisms of major surface proteins of Borrelia burgdorferi. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 2.33
Beta-lactam resistance in clinical isolates of Escherichia coli caused by elevated production of the ampC-mediated chromosomal beta-lactamase. Antimicrob Agents Chemother (1979) 2.32
In vitro inhibition of Borrelia burgdorferi growth by antibodies. J Infect Dis (1993) 2.31
Common evolutionary origin of chromosomal beta-lactamase genes in enterobacteria. J Bacteriol (1982) 2.24
Outer surface protein A (OspA) from the Lyme disease spirochete, Borrelia burgdorferi: high level expression and purification of a soluble recombinant form of OspA. Protein Expr Purif (1990) 2.23
Prevalence of Borrelia burgdorferi sensu lato-infected ticks on migrating birds. Appl Environ Microbiol (1995) 2.23
Escherichia coli K-12 mutants hyperproducing chromosomal beta-lactamase by gene repetitions. J Bacteriol (1977) 2.21
Linear plasmids of Borrelia burgdorferi have a telomeric structure and sequence similar to those of a eukaryotic virus. J Bacteriol (1991) 2.15
Neuroborreliosis during relapsing fever: review of the clinical manifestations, pathology, and treatment of infections in humans and experimental animals. Clin Infect Dis (1998) 2.15
Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun (1987) 2.15
Variable major proteins of Borrelia hermsii. Epitope mapping and partial sequence analysis of CNBr peptides. J Exp Med (1985) 2.12
Enzyme-linked immunosorbent assays for Lyme disease: reactivity of subunits of Borrelia burgdorferi. J Infect Dis (1989) 2.12
An outbreak of giardiasis in a group of campers. Am J Trop Med Hyg (1976) 2.04
The relapsing fever agent Borrelia hermsii has multiple copies of its chromosome and linear plasmids. Genetics (1992) 2.00
Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA. Infect Immun (1993) 1.98
A flagella-less mutant of Borrelia burgdorferi. Structural, molecular, and in vitro functional characterization. J Clin Invest (1991) 1.95
Reducing maternal mortality in Kigoma, Tanzania. Health Policy Plan (1995) 1.94
A Lyme borreliosis cycle in seabirds and Ixodes uriae ticks. Nature (1993) 1.91
Reactivation of Borrelia infection in birds. Nature (2000) 1.90
Socioeconomic status, pathogen burden and cardiovascular disease risk. Heart (2007) 1.90
Identification of a novel ampC beta-lactamase promoter in a clinical isolate of Escherichia coli. EMBO J (1982) 1.89
A family of surface-exposed proteins of 20 kilodaltons in the genus Borrelia. Infect Immun (1994) 1.89
Health for all by the year 2000? BMJ (1996) 1.88
Juxtaposition of expressed variable antigen genes with a conserved telomere in the bacterium Borrelia hermsii. Proc Natl Acad Sci U S A (1990) 1.87
Vaginal isolates of Staphylococcus aureus associated with toxic shock syndrome. Infect Immun (1981) 1.84
Emerging bacterial zoonotic and vector-borne diseases. Ecological and epidemiological factors. JAMA (1996) 1.82
Prostaglandins: members of a new hormonal system. These physiologically very potent compounds of ubiquitous occurrence are formed from essential fatty acids. Science (1967) 1.81
An OspB mutant of Borrelia burgdorferi has reduced invasiveness in vitro and reduced infectivity in vivo. Infect Immun (1993) 1.79
Comparison of the overlapping frd and ampC operons of Escherichia coli with the corresponding DNA sequences in other gram-negative bacteria. J Bacteriol (1983) 1.77
Nucleotide sequence and analysis of the gene in Borrelia burgdorferi encoding the immunogenic P39 antigen. FEMS Microbiol Lett (1994) 1.77
In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies. J Clin Microbiol (1992) 1.75
Access of antibody or trypsin to an integral outer membrane protein (P66) of Borrelia burgdorferi is hindered by Osp lipoproteins. Infect Immun (1999) 1.74
Immunochemical analysis of Lyme disease spirochetes. Yale J Biol Med (1985) 1.74
Expert advice and patient expectations: laboratory testing and antibiotics for Lyme disease. JAMA (1998) 1.73
Variability of a bacterial surface protein and disease expression in a possible mouse model of systemic Lyme borreliosis. J Exp Med (1994) 1.73
Properties of penicillin-binding proteins in Neisseria gonorrhoeae. Antimicrob Agents Chemother (1981) 1.72
Isolation and characterization of the Lyme disease spirochete from the skin of patients with erythema chronicum migrans. J Am Acad Dermatol (1985) 1.71
Syphilis in pregnant women in Mozambique. Genitourin Med (1985) 1.69
Variable antigen genes of the relapsing fever agent Borrelia hermsii are activated by promoter addition. Mol Microbiol (1991) 1.66
Campylobacter jejuni in black-headed gulls (Larus ridibundus): prevalence, genotypes, and influence on C. jejuni epidemiology. J Clin Microbiol (2002) 1.66
The Oms66 (p66) protein is a Borrelia burgdorferi porin. Infect Immun (1997) 1.65
Saccharomyces cerevisiae G1 cyclins are differentially involved in invasive and pseudohyphal growth independent of the filamentation mitogen-activated protein kinase pathway. Genetics (1999) 1.60
Antigenic variation and strain heterogeneity in Borrelia spp. Res Microbiol (1993) 1.60
Transhemispheric exchange of Lyme disease spirochetes by seabirds. J Clin Microbiol (1995) 1.57
Subtelomeric expression regions of Borrelia hermsii linear plasmids are highly polymorphic. Mol Microbiol (1992) 1.55
Cloning and sequence analysis of linear plasmid telomeres of the bacterium Borrelia burgdorferi. Mol Microbiol (1990) 1.54
Cardiovascular and metabolic response to infusions of prostaglandin E1 and to simultaneous infusions of noradrenaline and prostaglandin E1 in man. Prostaglandin and related factors 35. Acta Physiol Scand (1965) 1.52
The variable antigens Vmp7 and Vmp21 of the relapsing fever bacterium Borrelia hermsii are structurally analogous to the VSG proteins of the African trypanosome. Mol Microbiol (1990) 1.52
Arthritis severity and spirochete burden are determined by serotype in the Borrelia turicatae-mouse model of Lyme disease. Infect Immun (1997) 1.51
Occupational lead poisoning in the United States: clinical and biochemical findings related to blood lead levels. Br J Ind Med (1979) 1.50